Abstract:Objective: This study aimed to investigate the effect of Ubiquitin-Specific Peptidase 22 (USP22) on the inflammatory response mediated by BV-2 mouse microglia and explore the role of the PU box binding protein 1 (PU.1)/NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome in the USP22-induced polarization of BV-2 cells. Methods: The BV-2 mouse microglia line was cultured in vitro, and plasmid and siRNA transfection was performed to overexpress or knockdown USP22. Subsequently, BV-2 cells were treated with lipopolysaccharide (LPS) and interferon-gamma (IFN-γ) and interleukin (IL)-4 to induce M1 and M2 polarization, respectively. Western blot was used to detect the expression levels of USP22, PU.1, M1 polarization markers [inducible nitric oxide synthase (iNOS), and cluster of differentiation (CD) 86], M2 polarization markers [arginase 1 (Arg1), and CD206], in BV-2 cells from different treatment groups. Additionally, measurement was performed on the inflammasome NLRP3, and its activation-related proteins [NIMA-related kinase7 (NEK7), cleaved-caspase 1, apoptosis-associated speck-like protein containing a CARD (ASC)]. Enzyme-linked immunosorbent (ELISA) assay was employed to determine the levels of inflammatory cytokines tumor necrosis factor-alpha (TNF-α), IL-1 β, and IL-10 in the cells. Furthermore, immunofluorescence was utilized to analyze the levels of iNOS and Arg1-positive BV-2 cells in different treatment groups. Moreover, the ubiquitination level of PU.1 was detected using immunoprecipitation. Results: The protein expression level of USP22 was significantly down-regulated in BV-2 cells treated with M1 polarization. Overexpression of USP22 remarkably reduced the protein levels of iNOS and CD86, but markedly increased the protein levels of Arg1 and CD206 in cells. Besides, there was a notable reduction in the levels of TNF-α and IL-1 β in the cell culture medium, while a remarkable increase was observed in the level of IL-10. Additionally, the level of iNOS-positive cells was significantly decreased, while the level of Arg1-positive cells was considerably increased. However, up-regulation of PU.1 expression could reverse the above results and promoted the expression of NLRP3 and its activation-related proteins. Notably, overexpression of USP22 significantly down-regulated the protein expression and ubiquitination level of PU.1. Conclusion: USP22 inhibits the M1 polarization of BV-2 mouse microglia. The PU.1/NLRP3 inflammasome pathway may be a critical regulatory pathway of USP22 in BV-2 cell polarization.

USP22 Controls Inkt Immunity Through MED1 Suppression of Histone H2A Monoubiquitination

Histone Demethylases UTX and JMJD3 Are Required for NKT Cell Development in Mice

USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.

USP22 is a Positive Regulator of NFATc2 on Promoting IL2 Expression.

P037 USP16-mediated deubiquitination of calcineurin A controls peripheral T cells maintenance and attenuates intestinal inflammation

Usp16-Mediated Deubiquitination Of Calcineurin A Controls Peripheral T Cell Maintenance

USP1-regulated Reciprocal Differentiation of Th17 Cells and Treg Cells by Deubiquitinating and Stabilizing TAZ.

Ubiquitin-specific peptidase 18 regulates the differentiation and function of Treg cells

USP21 Prevents the Generation of T-helper-1-like Treg Cells

USP12 promotes CD4+ T cell responses through deubiquitinating and stabilizing BCL10

USP3 Inhibits Type I Interferon Signaling by Deubiquitinating RIG-I-like Receptors

USP28 protects development of inflammation in mouse intestine by regulating STAT5 phosphorylation and IL22 production in T lymphocytes

USP3 Plays a Critical Role in the Induction of Innate Immune Tolerance.

USP38 Couples Histone Ubiquitination and Methylation Via KDM5B to Resolve Inflammation

USP12 Positively Regulates M-MDSC Function to Inhibit Antitumour Immunity Through Deubiquitinating and Stabilizing P65.

Deubiquitination of aryl hydrocarbon receptor by USP21 negatively regulates T helper 17 cell differentiation

USP22 Inhibits Microglial M1 Polarization by Regulating the PU.1/NLRP3 Inflammasome Pathway

USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1

USP21 Negatively Regulates Antiviral Response by Acting As a RIG-I Deubiquitinase

USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms

Deubiquitinase USP47 attenuates virus-induced type I interferon signaling